Miasis Urogenital: Tinjauan Sistematis Literatur pada Irisan Urologi dan Entomologi
DOI:
https://doi.org/10.54259/sehatrakyat.v4i4.5980Keywords:
Urogenital Myiasis, Medical Entomology, Diptera, Ivermectin, Parasitic DiseaseAbstract
Urogenital myiasis (UGM) is a rare parasitic disease at the intersection of urology and medical entomology, caused by infestation of the urogenital tract with dipterous fly larvae. Despite its low prevalence, UGM poses significant diagnostic and therapeutic challenges. To systematically review the epidemiology, causative agents, clinical manifestations, diagnosis, and management of urogenital myiasis based on published literature from 2015 to 2025. A comprehensive literature search was conducted using PubMed, Scopus, and Google Scholar databases for articles published between 2015 and 2025. Keywords included "urogenital myiasis," "urinary myiasis," "bladder myiasis," and "genital myiasis." The PRISMA 2020 protocol was used for reporting this systematic review. Of 156 articles identified, 27 articles met the inclusion criteria. UGM accounts for only 0.7% of all human myiasis cases. The most common causative agents are Psychoda species (23.7%) and Cochliomyia species (11.8%). Risk factors include poor hygiene, low socioeconomic status, immunosuppression, and prolonged catheterization. Management involves mechanical removal of larvae, antiseptic irrigation, and adjunctive therapy with ivermectin. UGM remains an underreported condition requiring increased clinical awareness, particularly in developing countries. Early diagnosis and prompt management are essential to prevent complications.
Downloads
References
Bernhardt, V., Finkelmeier, F., Verhoff, M. A., & Amendt, J. (2019). Myiasis in humans—a global case report evaluation and literature analysis. Parasitology Research, 118(2), 389–397. https://doi.org/10.1007/s00436-018-6145-7
Bonkat, G., Bartoletti, R., Bruyère, F., Cai, T., Geerlings, S. E., Köves, B., Schubert, S., Pilatz, A., Veeratterapillay, R., & Wagenlehner, F. (2024). EAU Guidelines on Urological Infections (pocket). European Association of Urology 2024, March, 1–184.
Culha, M. G., Turker, K., Ozsoy, S., & Serefoglu, E. C. (2016). Urogenital myiasis caused by Psychoda albipennis. Saudi Medical Journal, 37(12), 1392–1394. https://doi.org/10.15537/smj.2016.12.16312
Doğan Demir, A., Iraz, M., & Sayın İpek, D. N. (2015). Urogenital myiasis caused by Psychoda albipennis in a child. Turk Pediatri Arsivi, 50(1), 65–68. https://doi.org/10.5152/tpa.2015.463
Failoc-Rojas, V. E., Silva-Díaz, H., Maguiña, J. L., Rodriguez-Morales, A. J., Díaz-Velez, C., Apolaya-Segura, M., & Valladares-Garrido, M. J. (2023). Evidence-based indications for ivermectin in parasitic diseases: An integrated approach to context and challenges in Peru. Parasite Epidemiology and Control, 23(July), 1–7. https://doi.org/10.1016/j.parepi.2023.e00320
Francesconia, F., & Lupi, O. (2012). Myiasis. Clinical Microbiology Reviews, 25(1), 79–105. https://doi.org/10.1128/CMR.00010-11
Ghimire, S., Adhikari, P., Shrestha, N., Luitel, B., Chalise, P. R., & Mandal, S. (2025). A rare case report of penile myiasis in a catheterized patient. International Journal of Surgery Case Reports, 126(October 2024), 110744. https://doi.org/10.1016/j.ijscr.2024.110744
Güven, E., Kar, S., Doğan, N., & Karaer, Z. (2008). Urogenital Myiasis Caused by Psycoda albipennis in a Woman. 32(2), 174–176.
Jallow, B. J. J., Gassara, G., Bajinka, O., Luo, Y., Liu, M., Cai, J., Huang, J., & Mengid, F. (2024). Human myiasis in Sub-Saharan Africa: A systematic review. PLoS Neglected Tropical Diseases, 18(3), 1–17. https://doi.org/10.1371/journal.pntd.0012027
Koeppen, R. L., & Tadros, N. N. (2020). Case report: Urogenital myiasis in an adult male. Urology Case Reports, 33, 101303. https://doi.org/10.1016/j.eucr.2020.101303
Kumar, M., Saikia, S., Das, A. K., Barmon, D., Baruah, U., Begum, D., & King, S. V. N. (2024). “A rare case of bladder myiasis mimicking radiation cystitis—A first case report.” Clinical Case Reports, 12(8), 1–6. https://doi.org/10.1002/ccr3.9240
Mandracchia, V. J., Hayes, D. W., Yoho, R. M., & Hayes, M. F. (2000). Urinary Tract Infections: Epidemiology, Mechanisms of Infection and Treatment Options. Nature Reviews Microbiology, 13(March), 269–284. https://doi.org/10.1038/nrmicro3432.Urinary
McCoy, O. O., Rabley, A., Prasad, M. M., & Rovner, E. S. (2016). A case of uncomplicated urinary myiasis in a healthy female. BMJ Case Reports, 2016, 1–3. https://doi.org/10.1136/bcr-2016-214783
Paul, S., Upreti, P., Makhija, A., & Nautiyal, R. (2021). Urogenital myiasis - an atypical presentation. Autopsy and Case Reports, 11. https://doi.org/10.4322/acr.2020.192
Payán-Gómez, C., Cabal-Herrera, A. M., Caicedo-Rosales, J. A., & Saldarriaga-Gil, W. (2022). Severe Vaginal Myiasis: Successful Management With Ivermectin. International Journal of Infectious Diseases, 122, 398–400. https://doi.org/10.1016/j.ijid.2022.06.021
Sayeed, A., Ahmed, A., Sharma, S. C., & Hasan, S. A. (2019). Ivermectin: A Novel Method of Treatment of Nasal and Nasopharyngeal Myiasis. Indian Journal of Otolaryngology and Head and Neck Surgery, 71(s3), 2019–2024. https://doi.org/10.1007/s12070-018-1444-y
Vaziri, S., Mohseni Afshar, Z., Rajabalian, M. B., Narouie, B., Sayad, B., Madani, S. H., Bartani, Z., Sedighi, M., Radpour, N., & Momeni, H. (2025). Urinary myiasis; a case report and literature review. Urology Case Reports, 59(February), 102992. https://doi.org/10.1016/j.eucr.2025.102992
Yigzaw, K. T., Engidaw, E. A., Asfaw, B. A., Wondemeneh, Y. A., Moges, M. T., & Getahun, G. M. (2025). Myiasis in a spinal cord injury patient with indwelling catheter: A case report from Gondar, Ethiopia. International Journal of Surgery Case Reports, 127(January), 110934. https://doi.org/10.1016/j.ijscr.2025.110934.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Muhammad Rozaqy Ishaq, Fitria Dewi Puspita Anggraini
This work is licensed under a Creative Commons Attribution 4.0 International License.
Hak cipta pada setiap artikel adalah milik penulis.
Penulis mengakui bahwa SEHATRAKYAT (Jurnal Kesehatan Masyarakat) sebagai publisher yang mempublikasikan pertama kali dengan lisensi Creative Commons Attribution 4.0 International License.
Penulis dapat memasukan tulisan secara terpisah, mengatur distribusi non-ekskulif dari naskah yang telah terbit di jurnal ini kedalam versi yang lain, seperti: dikirim ke respository institusi penulis, publikasi kedalam buku, dan lain-lain. Dengan mengakui bahwa naskah telah terbit pertama kali pada SEHATRAKYAT (Jurnal Kesehatan Masyarakat).
